Shelf life (days): 730.0
Formulation: A solid
Formal Name: (2S)-1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine-2,3,3,4,4,5,5-d7-carbonitrile
Purity: ≥99% deuterated forms (d1-d7)
Formula Markup: C17H18D7N3O2
Formula Weight: 310.4
CAS Number: 1133208-42-0
Notes: Vildagliptin-d7 is intended for use as an internal standard for the quantification of vildagliptin (Item No. 14705) by GC- or LC-MS. Vildagliptin is an inhibitor of dipeptidyl peptidase 4 (DPP-4; Ki = 0.003 µM).{24377} It is selective for DPP-4 over DPP-2, DPP-8, and DPP-9 (Kis = >500, 0.81, and 0.095 µM, respectively). Vildagliptin (3 mg/kg) decreases plasma glucose levels and increases plasma insulin levels during an oral glucose challenge in Zucker fa/fa rats.{24378} It prevents increases in liver triglyceride and thiobarbituric acid reactive substance (TBARS) levels in a mouse model of non-alcoholic fatty liver disease (NAFLD) induced by a high-cholesterol diet.{58931} Formulations containing vildagliptin have been used in the treatment of type 2 diabetes.